The invention relates to a construction method of a diffuse large B-
cell lymphoma prognosis evaluation model, which comprises the following steps: (1) collecting data required by an IPI
evaluation system of a patient, and detecting whether PIM1, EZH2, B2M, KLHL4, CD79b, MYC and STAT3 genes in a sample are mutated or not; (2) assigning an IPI according to an IPI
evaluation system scheme; (3) assigning values according to the
mutation states of PIM1, EZH2, B2M, KLHL4, CD79b, MYC and STAT3; (4) substituting the IPI
score obtained in the step (2) and the scores corresponding to the various
gene mutations obtained in the step (3) into a formula, and calculating to obtain an IPI-M value; and (5) grouping according to the IPI-M value calculated in the step (4), and performing prognosis evaluation. The diffuse large B-
cell lymphoma prognosis evaluation model is combined with molecular
mutation characteristics and fully considers the influence of
common gene mutation, so that a patient is comprehensively evaluated during primary diagnosis, important guidance is provided for subsequent treatment of the patient, and the diffuse large B-
cell lymphoma prognosis evaluation model has good clinical application value.